Methods and compositions for inhibition of angiogenesis with EM-138
US6518298B2 · kind B2 · utility
91Cited by
22References
49Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 20, 2001 |
| Grant date | Feb 11, 2003 |
| Priority date | — |
| Expiry date | Feb 20, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/535
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, the invention comprises the compound EM-138 and its use in the inhibition of angiogenesis and treatment of angiogenesis associate diseases, including the inhibition of tumor growth and metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.